Name: Examination of Proteins Bound to Nascent DNA in Mammalian Cells Using BrdU-ChIP-Slot-Western Technique (Video) | JoVE Journal
Uploaded: 2016-01-14T18:00:00.000+00:00
Duration: 9 min 14 s
Description: Learn BrdU-ChIP-Slot-Western to examine proteins bound to nascent DNA in mammalian cells. This rapid, quantitative method detects replication and repair protein interactions using NIH 3T3 cells.

ai_agent_IP

ai_agent

maintenance

instantTrialDurationMinutes

isBiopharma

enableNewMyJoveSectionDesign

educationFeatures

seoMetaApi

ai_copilot_institution_blacklist

ai_chat_institution_blacklist

freeAccessWindow

ssoRoleCapture

scheduledMaintenanceBanner

joveLabsFeatures

disable_autoplay_for_bots

extended_trial_duration

5 minutes

The work in this manuscript was supported by funds from Dept. of Radiation Oncology and Huntsman Cancer Institute and the National Institute of Health grant (R01-CA188520) to SB. I thank Danielle Johnson and Steven Bennett in my lab for demonstrating the protocol and explaining its benefits. I am grateful to Dr. Mahesh Chandrasekharan (Huntsman Cancer Institute) for critical comments on the manuscript.

1. Chromatin immunoprecipitation (ChIP) following BrdU Labeling
<ol>
	<li>Culture NIH3T3 cells in the presence of either DMSO or HDAC1,2-selective inhibitors as described previously6.</li>
	<li>Following treatment with DMSO or HDAC1,2 selective inhibitors, add BrdU to the cells in a sterile tissue culture hood. Incubate 2 x 106 NIH3T3 cells plated in 10 ml NIH3T3 media with a 20 &#181;M final concentration of bromodeoxyuridine (BrdU) for 60 min in a sterile 37 &#176;C tissue culture incubator.</li>
	<li>Crosslink intracellular proteins to DNA by adding formaldehyde directly to the culture media at a final concentration of 1%. Incubate 2 x 106 NIH3T3 cells with formaldehyde at RT&#160;for 10 min on a shaker.</li>
	<li>Quench the cross linking by the addition of glycine to a final concentration of 125 mM. Incubate at RT for 5 min on a shaker.</li>
	<li>Remove the media and collect cells in PBS in a 15 ml centrifuge tube. Spin cells at 956 x g for 5 min at 4 &#176;C. Wash the cell pellet twice with ice-cold PBS. Remove PBS from the tube. Store the cross-linked cell pellet without PBS (the supernatant) at -80 &#176;C until use.</li>
	<li>Prepare the lysate from the crosslinked cell pellet by adding 500 &#181;l FA140 buffer (50 mM of HEPES KOH pH 7.5, 140 mM of NaCl, 1 mM of EDTA (pH 8.0), 1% Triton-X-100 and 0.1% sodium deoxycholate) supplemented with protease inhibitor cocktail.</li>
	<li>Shear the chromatin by sonicating the samples five times at 35% power and with a 15 sec&#160;pulse, 0.9 sec on and 0.1 sec off setting. Keep the tubes on ice after every round of sonication to avoid heating of the samples.
	<ol>
		<li>Check the shearing on a DNA gel as the shearing efficiency will vary between different sonicators. To check sonication, reverse crosslink by adding NaCl to a concentration of 0.16 M and perform steps 1.17.1. - 1.22. Run eluted 10 &#181;l DNA on a 1.5% agarose gel to check whether the shearing is between 300 - 700 bp with an average intensity at 500 bp.</li>
	</ol>
	</li>
	<li>Following sonication, centrifuge samples for 10 min at 17,949 x g at 4 &#176;C and transfer the supernatant to a new tube.
	<ol>
		<li>Perform protein estimation using the commercial protein assay kit according to manufacturer&#39;s protocol. Use equal amount of lysate for ChIP of control and experimental samples. Generally, use 1 mg of total lysate per ChIP reaction.</li>
	</ol>
	</li>
	<li>Prepare 50% slurry of protein A-agarose using FA140 buffer containing protease inhibitor cocktail. Add 1/10 volume of the protease inhibitor cocktail. Calculate the volume of beads needed based on the number of samples in total.
	<ol>
		<li>Wash Protein A-agarose beads with FA140 buffer twice to remove the storage buffer and add an equal volume to FA140 buffer to the beads to make 50% slurry.</li>
		<li>To remove proteins that non-specifically bind to the beads, add 50 &#181;l of 50% slurry of Protein A-agarose and incubate the samples at 4 &#176;C with constant end-over-end rotation in a rotisserie mixer for 30 min.</li>
	</ol>
	</li>
	<li>Spin the samples at 956 x g at 4 &#176;C for a minute. Collect the supernatant and perform immunoprecipitation by adding either 8 &#956;l H4K16ac antibody or 5 &#956;l (5 &#956;g) of 1 mg/ml SMARCA5 antibody to the supernatant. Incubate at 4 &#176;C O/N&#160;with constant end-over-end rotation in a rotisserie mixer.</li>
	<li>Save 1/10th of the extract for &#39;input&#39; control and set it as aside at -20 &#176;C. The input needs to be reverse cross-linked along with the IP samples.</li>
	<li>Use equal amount of rabbit IgG (5&#160;&#956;l of 1 mg/ml) as the negative control immunoprecipitation sample.</li>
	<li>The following day, add 50 &#956;l of 50% protein A-agarose slurry to the extract and incubate for 1 hr at 4 &#176;C with rotation.</li>
	<li>Pellet agarose beads by centrifugation at 956 x g for 2 min at 4 &#176;C, carefully remove the supernatant and wash the beads with the following buffers sequentially. In buffer preparations, add protease inhibitors right before use.
	<ol>
		<li>Wash with Low Salt Immune Complex Wash Buffer (FA140; final concentration of 50 mM of HEPES KOH pH 7.5, 140 mM of NaCl, 1 mM of EDTA (pH 8.0), 1% Triton-X-100 and 0.1% Sodium deoxycholate) for 5 min at 4 &#176;C with end-over-end rotation.</li>
		<li>Wash with High Salt Immune Complex Wash Buffer (FA500; final concentration of 50 mM of HEPES KOH pH 7.5, 500 mM of NaCl, 1 mM of EDTA (pH 8.0), 1% Triton-X-100 and 0.1% Sodium deoxycholate) for 5 min at 4 &#176;C with end-over-end rotation.</li>
		<li>Wash with LiCl Immune Complex Wash Buffer (final concentration of 10 mM of Tris-Cl pH 8.0, 250 mM of LiCl, 0.5% NP40 and 0.5% Sodium deoxycholate) for 5 min at 4 &#176;C with end-over-end rotation.</li>
	</ol>
	</li>
	<li>Following washes as described above, add 200 &#181;l elution solution (final concentration of 1% SDS and 100 mM Sodium bicarbonate) and incubate at RT for 15 min with end-over-end rotation at RT.</li>
	<li>Spin the samples at 956 x g at RT and transfer the eluate to a new 1.5 ml tube. Repeat step 1.15 with additional 200 &#181;l elution solution.</li>
	<li>To 400 &#181;l of the eluate, add NaCl to a concentration of 0.16 M and mix well.
	<ol>
		<li>In addition, add 400 &#181;l elution solution to 10 &#181;l input that was set aside (step 1.11) and add NaCl to a concentration of 0.16 M to reverse crosslink input samples as well. Reverse crosslink the samples by incubating in 65 &#176;C water bath for 5 hr.</li>
	</ol>
	</li>
	<li>Add 1 ml&#160;of 100% EtOH to the reverse-crosslinked eluate. Mix well and incubate at -80 &#176;C for 2 - 3 hr or at -20 &#176;C O/N. Spin the samples at 17,949 x g for 15 min and discard ethanol.</li>
	<li>Add 800 &#181;l 70% ethanol to wash the pellet. Spin at 17,949 x g for 15 min at 4 &#176;C and discard ethanol. Spin briefly to remove any residual ethanol. Air-dry the samples at 37 &#176;C for 10 min to remove residual ethanol.</li>
	<li>Dissolve DNA in 90 &#181;l RNase and DNase free water and add 2 &#181;l 10 mg/ml RNase at a 0.2 mg/ml final concentration. Incubate at 37 &#176;C in water bath for 30 min.</li>
	<li>Add 10 &#181;l 10x&#160;Proteinase K Buffer (100 mM Tris-Cl pH 8.0, 50 mM EDTA pH 8.0, 5% SDS). Mix well and add 1 &#181;l Proteinase K. Incubate at 42 &#176;C for 1 hr.</li>
	<li>Purify input and ChIP DNA using commercial PCR purification kit according to manufacturer&#39;s protocol and elute DNA in 50 &#181;l water. Store DNA at -20 &#176;C until further use.</li>
</ol>
2. Slot Blot Analysis of ChIP DNA
<ol>
	<li>Measure the yield of input and ChIP DNA eluted in 50 &#181;l water as described in step 1.22 using a spectrophotometer at 280 nm according to manufacturer&#39;s protocol.</li>
	<li>Take equal volumes (50 &#181;l) of input or immunoprecipitated DNA that are within the linear range of detection.
	<ol>
		<li>For instance, if input DNA yield is 1.5 ng/&#181;l, then take 30 &#181;l (or 45 ng total DNA) and make volume to 50 &#181;l with water. For factor ChIP, take the entire 50 &#181;l eluate from Step 2.1 and proceed to step 2.3.</li>
	</ol>
	</li>
	<li>Denature 50 &#181;l input or immunoprecipitated DNA by adding 2.5 volumes of 0.4 N NaOH, briefly vortex and centrifuge for 956 x g for 10 sec, and incubate at RT for 30 min.</li>
	<li>Neutralize the denatured DNA by adding 175 &#181;l of 1 M Tris-HCl, pH 6.8, vortex, centrifuge for 956 x g for 10 sec and place the samples on ice.</li>
	<li>Prepare a serial dilution of input and immunoprecipitated DNA for the Slot Blot assay as described below.
	<ol>
		<li>Follow steps 2.3 - 2.4 to get a total sample volume of 350 &#181;l (i.e., 50 &#181;l Input/ChIP DNA, 125 &#181;l 0.4 N NaOH, 175 &#181;l 1 M Tris-HCl, pH 6.8). 
		Note: For the instance stated above, 45 ng of input DNA will end up being 0.129 ng/ &#181;l.</li>
		<li>For input DNA, label three tubes as 100, 50 and 25 and add 100 &#181;l, 50 &#181;l and 25 &#181;l of the denatured and neutralized DNA sample. Make the final volume to 100 &#181;l with nuclease-free water. For ChIP DNA, label three tubes as 200, 100 and 50 and add 200 &#181;l, 100 &#181;l and 50 &#181;l of the denatured and neutralized DNA sample. Make final volume to 200 &#181;l&#160;with nuclease free water.</li>
	</ol>
	</li>
	<li>Cut the membrane to the size of the Slot Blot apparatus. Pre-wet the membrane and blotting papers in 20x SSC before and prior to adding DNA. Assemble them into the Slot Blot apparatus according to the manufacturer&#39;s protocol.</li>
	<li>Pipet DNA from step 2.5.2 into appropriate slots. Apply vacuum slowly to pull the DNA onto the zeta-probe membrane. Stop vacuum after all samples have passed through the apparatus.
	<ol>
		<li>Disassemble the apparatus and immediately immobilize the DNA onto the membrane using a UV crosslinker. Have the DNA side up in the UV crosslinker and use the autocrosslink setting in the crosslinker. Follow manufacturer&#39;s protocol.</li>
	</ol>
	</li>
	<li>Detect BrdU on the slot blot by performing western blotting.
	<ol>
		<li>Block the membrane with 5% non-fat dry milk in PBS containing 0.1% Tween-20 (PBST) for 1 hr&#160;at RT to prevent the non-specific binding of antibodies to the membrane.</li>
		<li>Add primary anti-BrdU antibody (1:500 dilution) diluted in 1% non-fat dry milk in PBST and incubate the blot with the primary antibody for 3 hr at RT on a shaker. Wash the membrane with PBST three times after the primary antibody incubation.</li>
		<li>Add HRP-conjugated anti-mouse secondary antibody to the blot (1:5,000 dilution) and incubate at RT for 1 hr. Wash the membrane with PBST three times after the secondary antibody incubation. 
		NOTE: Use enough volume of the antibodies to completely cover the membrane during primary and secondary antibody incubations.</li>
	</ol>
	</li>
	<li>Prepare the ECL mix and add it to the blot according to the manufacturer&#39;s protocol. Incubate the membrane with ECL mix for 5 min at RT.
	<ol>
		<li>Place the membrane in an X-ray cassette, expose the membrane to the X-ray film and develop the blot using the manufacturer&#39;s protocol.</li>
		<li>Quantify the signal obtained for input and ChIPed DNA after scanning the blots using the Image J software according to manufacturer&#39;s protocol. For quantitation, use the signal that is within the linear range of detection in order to ensure accuracy of measurement.</li>
	</ol>
	</li>
</ol>

<ol><li>Podhorecka, M., Skladanowski, A., Bozko, P. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((H2AX+Phosphorylation%3A+Its+Role+in+DNA+Damage+Response+and+Cancer+Therapy%5BTitle%5D)+AND+%22J+nucleic+acids%22%5BJournal%5D)">H2AX Phosphorylation: Its Role in DNA Damage Response and Cancer Therapy.</a> J nucleic acids. , (2010).</li>
<li>Groth, A., Rocha, W., Verreault, A., Almouzni, G. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Chromatin+challenges+during+DNA+replication+and+repair%5BTitle%5D)+AND+%22%22%5BJournal%5D)">Chromatin challenges during DNA replication and repair.</a> 128, 721-733 (2007).</li>
<li>Demeret, C., Vassetzky, Y., Mechali, M. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Chromatin+remodelling+and+DNA+replication%3A+from+nucleosomes+to+loop+domains%5BTitle%5D)+AND+%22Oncogene%22%5BJournal%5D)">Chromatin remodelling and DNA replication: from nucleosomes to loop domains.</a> Oncogene. 20, 3086-3093 (2001).</li>
<li>Bhaskara, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Deletion+of+histone+deacetylase+3+reveals+critical+roles+in+S+phase+progression+and+DNA+damage+control%5BTitle%5D)+AND+%22Mol+Cell%22%5BJournal%5D)">Deletion of histone deacetylase 3 reveals critical roles in S phase progression and DNA damage control.</a> Mol Cell. 30, 61-72 (2008).</li>
<li>Bhaskara, S., Hiebert, S. W. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Role+for+histone+deacetylase+3+in+maintenance+of+genome+stability%5BTitle%5D)+AND+%22Cell+Cycle%22%5BJournal%5D)">Role for histone deacetylase 3 in maintenance of genome stability.</a> Cell Cycle. 10, 727-728 (2011).</li>
<li>Bhaskara, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Histone+deacetylases+1+and+2+maintain+S-phase+chromatin+and+DNA+replication+fork+progression%5BTitle%5D)+AND+%22Epigenetics+Chromatin%22%5BJournal%5D)">Histone deacetylases 1 and 2 maintain S-phase chromatin and DNA replication fork progression.</a> Epigenetics Chromatin. 6, 27(2013).</li>
<li>Bhaskara, S., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Hdac3+is+essential+for+the+maintenance+of+chromatin+structure+and+genome+stability%5BTitle%5D)+AND+%22Cancer+Cell%22%5BJournal%5D)">Hdac3 is essential for the maintenance of chromatin structure and genome stability.</a> Cancer Cell. 18, 436-447 (2010).</li>
<li>Johnson, D. P., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((HDAC1%2C2+inhibition+impairs+EZH2-+and+BBAP-mediated+DNA+repair+to+overcome+chemoresistance+in+EZH2+gain-of-function+mutant+diffuse+large+B-cell+lymphoma%5BTitle%5D)+AND+%22Oncotarget%22%5BJournal%5D)">HDAC1,2 inhibition impairs EZH2- and BBAP-mediated DNA repair to overcome chemoresistance in EZH2 gain-of-function mutant diffuse large B-cell lymphoma.</a> Oncotarget. 6, 4863-4887 (2015).</li>
<li>Bhaskara, S. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Histone+deacetylases+1+and+2+regulate+DNA+replication+and+DNA+repair%3A+potential+targets+for+genome+stability-mechanism-based+therapeutics+for+a+subset+of+cancers%5BTitle%5D)+AND+%22Cell+Cycle%22%5BJournal%5D)">Histone deacetylases 1 and 2 regulate DNA replication and DNA repair: potential targets for genome stability-mechanism-based therapeutics for a subset of cancers.</a> Cell Cycle. 14, 1779-1785 (2015).</li>
<li>Taddei, A., Roche, D., Sibarita, J. B., Turner, B. M., Almouzni, G. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Duplication+and+maintenance+of+heterochromatin+domains%5BTitle%5D)+AND+%22J+Cell+Biol%22%5BJournal%5D)">Duplication and maintenance of heterochromatin domains.</a> J Cell Biol. 147, 1153-1166 (1999).</li>
<li>Alabert, C., Groth, A. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Chromatin+replication+and+epigenome+maintenance%5BTitle%5D)+AND+%22Nat+Rev+Mol+Cell+Biol%22%5BJournal%5D)">Chromatin replication and epigenome maintenance.</a> Nat Rev Mol Cell Biol. 13, 153-167 (2012).</li>
<li>Clapier, C. R., Cairns, B. R. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Regulation+of+ISWI+involves+inhibitory+modules+antagonized+by+nucleosomal+epitopes%5BTitle%5D)+AND+%22Nature%22%5BJournal%5D)">Regulation of ISWI involves inhibitory modules antagonized by nucleosomal epitopes.</a> Nature. 492, 280-284 (2012).</li>
<li>Sirbu, B. M., et al. <a target="_blank" href="http://www.ncbi.nlm.nih.gov/pubmed?term=((Analysis+of+protein+dynamics+at+active%2C+stalled%2C+and+collapsed+replication+forks%5BTitle%5D)+AND+%22Genes+Dev%22%5BJournal%5D)">Analysis of protein dynamics at active, stalled, and collapsed replication forks.</a> Genes Dev. 25, 1320-1327 (2011).</li>
</ol>

I have no competing financial interests.

The protocol described in this manuscript is a relatively quick method to demonstrate the presence of proteins or their post-translationally modified forms on newly replicated or nascent DNA. Additionally, this technique permits one to measure the association-dissociation kinetics of a protein or its modified form with nascent DNA. This technique is complementary to the elegant iPOND technology13. In the iPOND technology, newly synthesized DNA is labeled with ethyl deoxyuridine (EdU). A biotin conjugate is the...

Defective DNA repair and/or DNA replication are a major cause of genome instability, which can trigger cell death. A single unrepaired double strand break is sufficient to cause cell death1. Chromatin organization is transiently altered during both replication and repair2,3, and failure to maintain epigenetic information during these processes will result in a threat to genome integrity. Loss of HDAC3 or HDAC1,2 function impedes S-phase progression,&#160;DNA replication and repair leading to genotoxic stress (DNA damage) and cell&#160;death4-9. It is therefore a practical strategy to use selective HDAC inhibitors to disrupt replication, repair and chromatin in cancer cells and cause DNA damage, which in turn can stop growth and induce cell death selectively in rapidly growing cancer cells.
During DNA replication, chromatin is rapidly disassembled and then reassembled following DNA duplication. Newly synthesized histone H4 is acetylated at K5 and K12 residues (H4K5K12ac) and following deposition onto chromatin, they are rapidly deacetylated by histone deacetylases (HDACs)10,11. Failure of cells to maintain nascent chromatin integrity by histone deacetylation can lead to fork collapse, which in turn can result in DNA damage and cell death. We recently showed that selective inhibition of HDAC1,2 increases histone acetylation (H4K5ac, H4K12ac and H4K16ac) and inhibits SMARCA5 chromatin remodeler activity on nascent chromatin, which correlates with reduced replication fork progression, increased fork collapse and increased replication stress-induced DNA damage6. Thus, HDAC inhibitor treatment can alter nascent chromatin structure to trigger DNA damage and death very quickly in cancer cells, as these cells cycle rapidly and pass many times through the S-phase. It is therefore important to understand how HDACs function to regulate histone acetylation and protein binding to maintain DNA replication in mammalian cells.
To quantitatively measure the amount of histone acetylation and SMARCA5 chromatin remodeler associated with nascent DNA during DNA replication, we devised a modified ChIP assay called the BrdU-ChIP-Slot-Western technique. Following chromatin immunoprecipitation (ChIP) of a desired protein or histone modification, the amount of nascent DNA (labeled using thymidine analog, BrdU) in the ChIP sample can be detected using western analysis of BrdU-labeled ChIP DNA transferred onto a membrane using a Slot Blot apparatus. Using this technique, we showed that H4K16ac (a mark involved in chromatin packaging) and the ISWI family member SMARCA5 (SWI/SNF-related matrix-associated actin-dependent regulator of chromatin) chromatin remodeler are associated with nascent DNA in S-phase cells6. We also found that the nascent H4K16ac mark is deacetylated by HDAC1,2 during DNA replication6. H4K16ac inhibits chromatin remodeler activity of the ISWI family member SMARCA512. Hence, using the BrdU-CHIP-Slot-Western technique, we could connect the functions for HDAC1,2 in regulating chromatin remodeling during DNA replication. Hence, the BrdU-ChIP-Slot-Western Blot technique is a powerful approach to quantitatively measure the association and dissociation dynamics of proteins or their post-translational modifications that are bound to nascent DNA.

<table><tbody><tr><td>Anti-BrdU (westerns)</td><td>BD Biosciences</td><td>B555627</td><td></td></tr><tr><td>Anti-SMARCA5</td><td>Abcam</td><td>ab3749</td><td></td></tr><tr><td>Anti-H4K16ac</td><td>Active Motif</td><td>39167</td><td></td></tr><tr><td>Zeta-Probe GT Membrane</td><td>Bio-Rad</td><td>162-0197</td><td></td></tr><tr><td>Formaldehyde</td><td>Fisher</td><td>BP531-500</td><td></td></tr><tr><td>Protein A agarose</td><td>Millipore</td><td>16-156</td><td></td></tr><tr><td>Rnase A</td><td>Qiagen</td><td>19101</td><td></td></tr><tr><td>Proteinase K</td><td>Sigma</td><td>P4850</td><td></td></tr><tr><td>PCR Purification Kit</td><td>Qiagen</td><td>28106</td><td></td></tr><tr><td>Glycine</td><td>Sigma</td><td>G7403</td><td></td></tr><tr><td>Protease inhibitor cocktail</td><td>Roche</td><td>11836170001</td><td></td></tr><tr><td>BrdU</td><td>Sigma</td><td>B9285</td><td></td></tr><tr><td>Rabbit IgG&amp;nbsp;</td><td>Millipore</td><td>12-370</td><td></td></tr><tr><td>HEPES</td><td>Sigma</td><td>H3375</td><td></td></tr><tr><td>NaCl</td><td>Sigma</td><td>S-3014</td><td></td></tr><tr><td>Triton-X-100</td><td>Sigma</td><td>93443</td><td></td></tr><tr><td>NP40</td><td>USB Corporation</td><td>19628</td><td></td></tr><tr><td>Sodium deoxycholate</td><td>Sigma</td><td>D6750</td><td></td></tr><tr><td>Sodium bicarbonate</td><td>Sigma</td><td>S-4019</td><td></td></tr><tr><td>Ethanol</td><td>Decon Laboratories</td><td>04-355-222</td><td></td></tr><tr><td>DEPC-treated water</td><td>Sigma</td><td>95284</td><td></td></tr><tr><td>Tris</td><td>Fisher</td><td>BP-152-5</td><td></td></tr><tr><td>EDTA</td><td>Invitrogen</td><td>15575-020</td><td></td></tr><tr><td>SDS</td><td>Ambion</td><td>AM9820</td><td></td></tr><tr><td>Sodium hydroxide</td><td>Mallinckrodt GenAR&amp;nbsp;</td><td>MAL7772-06</td><td></td></tr><tr><td>20x SSC</td><td>Life Technologies</td><td>15557-036</td><td></td></tr><tr><td>Non-fat dry milk</td><td>Lab Scientific Inc</td><td>M0841</td><td></td></tr><tr><td>ECL</td><td>Thermo Fisher</td><td>80196</td><td></td></tr><tr><td>X-ray film</td><td>Genesee Sci</td><td>30-101</td><td></td></tr><tr><td>Developer</td><td>Konica Minolta</td><td>SRX-101A</td><td></td></tr><tr><td>UV Crosslinker</td><td>Stratagene</td><td>XLE-1000</td><td></td></tr><tr><td>Sonicator</td><td>Branson Sonifier&amp;nbsp; Digital Ultrasonic Cell Disruptor</td><td>Model: 450</td><td></td></tr><tr><td>Centrifuge</td><td>Eppendorf</td><td>Model: 5810R</td><td></td></tr><tr><td>Water bath</td><td>Fisher Scientific Isotemp</td><td>Model: 2322</td><td></td></tr><tr><td>NanoDrop 1000 spectrophotometer</td><td>ThermoScientific</td><td>Model: 1000</td><td></td></tr><tr><td>Slot Blot apparatus&amp;nbsp;</td><td>Schleicher and Schuell Minifold II</td><td>44-27570</td><td></td></tr><tr><td>Tissue Culture Incubator</td><td>Thermo Scientific</td><td>Series II 3110 Water-Jacketed CO2 Incubators</td><td></td></tr></tbody></table>

examination of proteins bound to nascent dna in mammalian cells using  brdu-chip-slot-western technique

Examination of Proteins Bound to Nascent DNA in Mammalian Cells Using  BrdU-ChIP-Slot-Western Technique

Histone deacetylases 1 and 2 (HDAC1,2) localize to the sites of DNA replication. In the previous study, using a selective inhibitor and a genetic knockdown system, we showed novel functions for HDAC1,2 in replication fork progression and nascent chromatin maintenance in mammalian cells. Additionally, we used a BrdU-ChIP-Slot-Western technique that combines chromatin immunoprecipitation (ChIP) of bromo-deoxyuridine (BrdU)-labeled DNA with slot blot and Western analyses to quantitatively measure proteins or histone modification associated with nascent DNA.
Actively dividing cells were treated with HDAC1,2 selective inhibitor or transfected with siRNAs against Hdac1 and Hdac2 and then newly synthesized DNA was labeled with the thymidine analog bromodeoxyuridine (BrdU). The BrdU labeling was done at a time point when there was no significant cell cycle arrest or apoptosis due to the loss of HDAC1,2 functions. Following labeling of cells with BrdU, chromatin immunoprecipitation (ChIP) of histone acetylation marks or the chromatin-remodeler was performed with specific antibodies. BrdU-labeled input DNA and the immunoprecipitated (or ChIPed) DNA was then spotted onto a membrane using the slot blot technique and immobilized using UV. The amount of nascent DNA in each slot was then quantitatively assessed using Western analysis with an anti-BrdU antibody. The effect of loss of HDAC1,2 functions on the levels of newly synthesized DNA-associated histone acetylation marks and chromatin remodeler was then determined by normalizing the BrdU-ChIP signal obtained from the treated samples to the control samples.

To determine the specificity of HDAC1,2-selective inhibitors, Hdac1,2FL/FL and Hdac3FL/FL fibrosarcoma cells were used. Adenovirus-containing Cre recombinase (Ad-Cre) was used to delete Hdac1,2 and Hdac3 in these cells. Following Ad-Cre infection of Hdac1,2FL/FL cells, a robust increase in H4K5ac was observed. Treatment of Hdac1,2 knockout cells with 233 or 898 did not result in any ...

In this protocol, we describe a novel BrdU-ChIP-Slot-Western technique to examine proteins and histone modifications associated with newly synthesized or nascent DNA.

Histone deacetylases 1 and 2 (HDAC1,2) localize to the sites of DNA replication. In the previous study, using a selective inhibitor and a genetic ...

The overall goal of this procedure is to rapidly examine proteins bound to nascent DNA with accuracy using BrdU labeling and chromatin precipitation. This method can answer key questions in the replication, repair in chromatin field, such as, what proteins are bound to nascent DNA during DNA replication and what repair proteins are bound to nascent DNA during replication stress. The main advantage of this technique is that it is a relatively quick method to detect proteins bound to nascent DNA in a highly quantitative manner.To begin, set up cultures of two million NIH 3T3 cells in 10 milliliters of media with either DMSO or inhibitors. Also, add BrdU to a final concentration of 20 micromolar. Once plated, incubate the cells for 60 minutes.After an hour, crosslink the intracellular proteins to the DNA by adding formaldehyde directly to the culture medium to a concentration of 1%by volume. Then, let the cells incubate at room temperature for 10 minutes with agitation. After 10 minutes, quench the reaction by adding glycine to the media to 125 millimolar and continue the incubation for five more minutes.Next, collect the cells in PBS and wash them twice with PBS using centrifugation. The pellet can be frozen at 80 degrees Celsius per storage if desired. Now, prepare the lysate from the crosslinked cells, add 500 microliters of FA140 buffer supplemented with the protease inhibitor cocktail to the pellet and shear the chromatin using five 15-second pulses of sonication.Keep the cells chilled between the pulses. Then, run 10 microliters of sample out on a 1.5%gel to diagnose the efficiency of the shearing. Once sheared, centrifuge the samples for 10 minutes, and transfer the supernatant to a new tube.Then, estimate the protein concentration in the supernatant using a kit. Next, prepare a 50%slurry of Protein A Agarose beads with FA140 buffer containing protease inhibitor. Add 50 microliters of the slurry to each sample and incubate the samples at 4 degrees Celsius with constant end-over-end rotation for 30 minutes.After half an hour, spin down the samples for a minute around 1000 G's in a refrigerated centrifuge. Then, collect the supernatant containing the labelled chromatin. Before proceeding, save 1/10th of the extract at 20 degrees Celsius to later serve as the input control.To immunoprecipitate the chromatin, add either eight microliters of H4K16ac antibody or five micrograms of SMARCA5 antibody to the supernatants. Also, add five micrograms of rapid IgG to the extract that serves as the negative control sample. Incubate the chromatin at 4 degrees Celsius overnight on a rotisserie mixer.The next day, add 50 microliters of the prepared 50%Protein A Agarose slurry to the immunoprecipitations and incubate the mixtures for an hour at 4 degrees Celsius with rotation. After an hour, pellet the Agarose beads and carefully discard the supernatant. Now, wash the beads using end-over-end rotations at 4 degrees Celsius in three sequential buffers.First, use freshly prepared, low-salt immune complex wash buffer for five minutes. Second, use freshly prepared, high-salt immune complex wash buffer for five minutes. Third, use freshly prepared, Lithium chloride immune complex wash buffer for five minutes.Following washes, add elution solution to the samples as described in the text. Spin the samples and transfer the eluate to a new 1.5 milliliter tube. Now, incubate the samples at 65 degrees Celsius for 5 hours to reverse the crosslinking.Later, precipitate the DNA. Add one milliliter of 100%ethanol to the samples and mix well. Then, incubate them at 80 degrees Celsius for two to three hours or overnight at 20 degrees Celsius.After the precipitation, remove the ethanol with a 15-minute ceintrifugation at 18000 G's. Then, following the text protocol, wash the pellet, treat the samples with RNase, then Proteinase K, purify DNA as described in the text, and finally, store at 20 degrees Celsius. To begin, measure the yield of input and ChIP DNA on a spectrophotometer.Then, denature the samples. Add 2.5 volumes of 0.4 normal sodium hydroxide, briefly vortex and centrifuge and incubate the samples at room temperature for 30 minutes. Next, neutralize the denatured DNA by adding 175 microliters of one molar Tris hydochloride pH 6.8.Vortex, centrifuge, and place the samples on ice. Now, prepare serial dilutions of the input and immunoprecipitated DNA and proceed with the slot-blot assay as described in the text protocol. After the DNA on the blot has been UV immobilized, detect the BrdU on the slot blot using western blotting.First, block the membrane with 5%nonfat dry milk in PBST for an hour at room temperature to prevent nonspecific binding. Next, prepare a bath of 1%nonfat dry milk in PBST with added 1:500 diluted anti-BrdU antibody. Incubate the blot in this bath for three hours at room temperature on a shaker.Afterwards, wash the membrane with PBST three times. Then, submerge the blot in a 1:5000 dilution of HRP conjugated anti-mouse secondary antibody in PBST. Incubate at room temperature for an hour with shaking.Use three washes with PBST to remove the secondary and analyse the result. The BrdU H4K16ac ChIP slot western technique was used to determine the amount of H4K16ac associated with nascent DNA. A robust enrichment in H4K16ac associated with nascent DNA was observed when compared to the rapid IgG control.Following inhibition of HDAC1/2 with compound 233, an increase in nascent-DNA-associated H4K16ac was observed. The same result was obtained using compound 898. Finally, the level of SMARCA5 chromatin remodeler on nascent DNA was determined using the BrdU SMARCA5 ChIP slot western technique.Indeed, SMARCA5 associated with nascent DNA and compound 898 did not change the levels of SMARCA5. After watching this video, you should have a good understanding of the changes that occur in chromatin and chromatin-modifying enzymes during DNA replication in mammalian cells. After its development, this technique paved the way for researchers in the field of replication to explore chromatin changes on nascent DNA as well as dynamics of DNA repair proteins on nascent DNA.In the future, this technique could also be used to study the dynamics of the DNA damage response and DNA repair proteins at the stalled fork in addition to studying the histone modifications and chromatin modifying enzymes at the fork.

examination-proteins-bound-to-nascent-dna-mammalian-cells-using-brdu

Research

JoVE Journal

Biology

Determining the cell cycle position of a population of cells, or understanding how signals affect proliferation, can be readily measured by flow cytometry using this protocol.  We report a simple experimental approach to staining cells and quantifying their position in the cell cycle.

Analysis of Cell Cycle Position in Mammalian Cells

A quantitative method for the analysis of chromosome replication timing is described. The method utilizes BrdU incorporation in combination with fluorescent in situ hybridization (FISH) to assess replication timing of mammalian chromosomes. This technique allows for the direct comparison of rearranged and un-rearranged chromosomes within the same cell.

Chromosome Replicating Timing Combined with Fluorescent In situ Hybridization

This video describes the protocol for BrdU immunofluorescence staining. The technique allows the identification of cells in different phases of cell cycle. Addition of DNA dyes and antibody labeling allows the detailed analysis of the fate of the S phase cells at later times.

BrdU Immunofluorescence Staining: A Technique to Identify Cells in Different Phases of Cell Cycle

This video article describes an in vitro microarray based method to determine the gene targets and binding sites for two component system response regulators.

DNA-affinity-purified Chip (DAP-chip) Method to Determine Gene Targets for Bacterial Two component Regulatory Systems

Studying DNA damage repair kinetics requires a system to induce lesions at defined sub-nuclear regions. We describe a method to create localized double-stranded breaks using a laser-scanning confocal microscope equipped with a 405 nm laser and provide automated procedures to quantify the dynamics of repair factors at these lesions.

Investigation of Protein Recruitment to DNA Lesions Using 405 Nm Laser Micro-irradiation

Ribonucleotides are among the most abundant non-canonical nucleotides incorporated into the genome during eukaryotic nuclear DNA replication. If not properly removed, ribonucleotides can cause DNA damage and mutagenesis. Here, we present two experimental approaches that are used to assess the abundance of ribonucleotide incorporation into DNA and its mutagenic effects.

Studying Ribonucleotide Incorporation: Strand-specific Detection of Ribonucleotides in the Yeast Genome and Measuring Ribonucleotide-induced Mutagenesis

In the present protocol, we demonstrate how to visualize DNA double-strand end resection during S/G2 phase of the cell cycle using an immunofluorescence-based method.

Assessment of Global DNA Double-Strand End Resection using BrdU-DNA Labeling coupled with Cell Cycle Discrimination Imaging

The present protocol highlights a modified method to detect and quantify DNA-protein crosslinks (DPCs) and their post-translational modifications (PTMs), including ubiquitylation, SUMOylation, and ADP-ribosylation induced by topoisomerase inhibitors and by formaldehyde, thereby allowing the study of the formation and repair of DPCs and their PTMs.

Quantitative Detection of DNA-Protein Crosslinks and Their Post-Translational Modifications

The following protocol presents the detection of single-stranded DNA foci in the G1 phase of the cell cycle utilizing cell cycle synchronization followed by RPA2 immunofluorescent staining.

Visualizing Single-Stranded DNA Foci in the G1 Phase of the Cell Cycle

Enrichment and sequencing of protein-associated nascent DNA (eSPAN) was developed to detect the relative abundance of a chromatin-associated protein on two replicating DNA strands, thereby revealing molecular insight into chromatin replication and its coupled processes. This protocol describes eSPAN procedures in yeast and mouse embryonic stem (ES) cells.

Strand-Specific Analysis of Proteins at Replicating DNA Strands by Enrichment and Sequencing of Protein-Associated Nascent DNA Method

Laminopathy disorders often lead to changes in the nuclear envelope, which may cause nuclear blebbing and leakage. This study presents an immunofluorescence method to visualize the nuclear lamina along with double-stranded DNA (dsDNA), providing a means to assess nuclear structure and integrity in mammalian cells.

Detection of Nuclear Blebbing and DNA Leakage in Mammalian Cells by Immunofluorescence

Learn BrdU-ChIP-Slot-Western to examine proteins bound to nascent DNA in mammalian cells. This rapid, quantitative method detects replication and repair protein interactions using NIH 3T3 cells.

Examination of Proteins Bound to Nascent DNA in Mammalian Cells Using BrdU-ChIP-Slot-Western Technique

Explore More Videos